Journal
ENDOCRINOLOGY
Volume 141, Issue 10, Pages 3871-3878Publisher
ENDOCRINE SOC
DOI: 10.1210/endo.141.10.7711
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL-63423, HL-35522] Funding Source: Medline
Ask authors/readers for more resources
To determine the role of aldosterone in mediating cardiovascular damage, we performed ablation/replacement experiments with aldosterone in a rat model of cardiac injury, Administration of angiotensin II and N-omega-nitro-L-arginine methyl ester (L-NAME; nitric oxide synthesis inhibitor) to male rats drinking 1% saline caused hypertension, severe biventricular myocardial necrosis, proteinuria, and fibrinoid necrosis of renal and cardiac vessels. Removal of aldosterone by adrenalectomy or through administration of the selective aldosterone antagonist eplerenone markedly reduced the cardiac and renal damage without significantly altering blood pressure. Aldosterone infusion in adrenalectomized, glucocorticoid-replaced L-NAME/angiotensin II-treated animals restored damage. Thus, we identified aldosterone as a critical mediator of L-NAME/angiotensine II induced vascular damage through mechanisms apparently independent of its effects on systolic blood pressure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available